NDRAW
UBS Group’s ENDRA Life Sciences Inc. Warrants NDRAW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,834
| Closed | – | – | 10445 |
|
|
2022
Q1 | $0 | Buy |
16,834
+10,233
| +155% | – | ﹤0.01% | 10133 |
|
|
2021
Q4 | $1K | Buy |
6,601
+3,068
| +87% | +$465 | ﹤0.01% | 9058 |
|
|
2021
Q3 | $1K | Buy |
3,533
+1,797
| +104% | +$509 | ﹤0.01% | 8268 |
|
|
2021
Q2 | $1K | Buy |
1,736
+360
| +26% | +$207 | ﹤0.01% | 8191 |
|
|
2021
Q1 | $1K | Buy |
1,376
+1,080
| +365% | +$785 | ﹤0.01% | 7826 |
|
|
2020
Q4 | $0 | Sell |
296
-1,055
| -78% | – | ﹤0.01% | 7815 |
|
|
2020
Q3 | $0 | Buy |
1,351
+745
| +123% | – | ﹤0.01% | 7585 |
|
|
2020
Q2 | $0 | Buy |
606
+483
| +393% | – | ﹤0.01% | 7463 |
|
|
2020
Q1 | $0 | Sell |
123
-55
| -31% | – | ﹤0.01% | 7372 |
|
|
2019
Q4 | $0 | Sell |
178
-7,100
| -98% | – | ﹤0.01% | 7303 |
|
|
2019
Q3 | $2K | Sell |
7,278
-3,232
| -31% | -$888 | ﹤0.01% | 6807 |
|
|
2019
Q2 | $7K | Sell |
10,510
-2,120
| -17% | -$1.41K | ﹤0.01% | 6396 |
|
|
2019
Q1 | $8K | Sell |
12,630
-4,520
| -26% | -$2.86K | ﹤0.01% | 6135 |
|
|
2018
Q4 | $9K | Buy |
17,150
+16,450
| +2,350% | +$8.63K | ﹤0.01% | 6381 |
|
|
2018
Q3 | $0 | Sell |
700
-700
| -50% | – | ﹤0.01% | 7269 |
|
|
2018
Q2 | $1K | Sell |
1,400
-1,800
| -56% | -$1.29K | ﹤0.01% | 6932 |
|
|
2018
Q1 | $2K | Sell |
3,200
-1,210
| -27% | -$756 | ﹤0.01% | 6679 |
|
|
2017
Q4 | $6K | Buy |
+4,410
| New | +$6K | ﹤0.01% | 6351 |
|
|
2017
Q3 | – | Sell |
-300
| Closed | – | – | 6973 |
|
|
2017
Q2 | $0 | Buy |
+300
| New | – | ﹤0.01% | 6958 |
|